Idarucizumab 2.5 Gm/ Intravenous [Praxbind]
Intracranial Hemorrhage
University Hospital, EssenDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Intracranial Hemorrhage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DABIGATRAN ETEXILATE University Hospital, Essen | D |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →